These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18350479)

  • 1. Thrombin-activatable fibrinolysis inhibitor and cardiovascular risk factors in polycystic ovary syndrome.
    Erdoğan M; Karadeniz M; Alper GE; Tamsel S; Uluer H; Cağlayan O; Saygili F; Yilmaz C
    Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):143-7. PubMed ID: 18350479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients.
    Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Yilmaz C
    Int J Immunogenet; 2009 Oct; 36(5):283-8. PubMed ID: 19744034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.
    Oral B; Mermi B; Dilek M; Alanoğlu G; Sütçü R
    Gynecol Endocrinol; 2009 Feb; 25(2):110-6. PubMed ID: 19253106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome.
    Karakurt F; Gumus II; Bavbek N; Kargili A; Koca C; Selcoki Y; Ozbek M; Kosar A; Akcay A
    Gynecol Endocrinol; 2008 Sep; 24(9):491-7. PubMed ID: 18958767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome.
    Luque-Ramírez M; Mendieta-Azcona C; Alvarez-Blasco F; Escobar-Morreale HF
    Hum Reprod; 2007 Dec; 22(12):3197-203. PubMed ID: 17933750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.
    Kaya C; Pabuccu R; Berker B; Satiroglu H
    Fertil Steril; 2010 Mar; 93(4):1200-7. PubMed ID: 19131059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
    Słopień R; Lewandowski K; Kolacz E; Zawilska K; Warenik-Szymankiewicz A
    Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M; Aydemir M; Tuzcu A
    Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
    Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
    Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinol-binding protein in nonobese women with polycystic ovary syndrome.
    Lee JW; Im JA; Lee DC; Lee HR; Shim JY
    Clin Endocrinol (Oxf); 2008 May; 68(5):786-90. PubMed ID: 17986278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome.
    Adali E; Yildizhan R; Kurdoglu M; Bugdayci G; Kolusari A; Sahin HG
    Fertil Steril; 2010 Jul; 94(2):666-72. PubMed ID: 19368913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk factors in polycystic ovary syndrome.
    Karaer A; Cavkaytar S; Mert I; Buyukkagnici U; Batioglu S
    J Obstet Gynaecol; 2010 May; 30(4):387-92. PubMed ID: 20455724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of polycystic ovary syndrome with cardiovascular risk factors.
    Akram T; Hasan S; Imran M; Karim A; Arslan M
    Gynecol Endocrinol; 2010 Jan; 26(1):47-53. PubMed ID: 19639500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade chronic inflammation is not accompanied by structural arterial injury in polycystic ovary syndrome.
    Costa LO; dos Santos MP; Oliveira M; Viana A
    Diabetes Res Clin Pract; 2008 Aug; 81(2):179-83. PubMed ID: 18499295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.